Cargando…

How COVID-19 disrupts glycometabolic control

Detalles Bibliográficos
Autor principal: Starling, Shimona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202046/
https://www.ncbi.nlm.nih.gov/pubmed/34127837
http://dx.doi.org/10.1038/s41574-021-00526-w
_version_ 1783707906152071168
author Starling, Shimona
author_facet Starling, Shimona
author_sort Starling, Shimona
collection PubMed
description
format Online
Article
Text
id pubmed-8202046
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82020462021-06-15 How COVID-19 disrupts glycometabolic control Starling, Shimona Nat Rev Endocrinol Research Highlight Nature Publishing Group UK 2021-06-14 2021 /pmc/articles/PMC8202046/ /pubmed/34127837 http://dx.doi.org/10.1038/s41574-021-00526-w Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Highlight
Starling, Shimona
How COVID-19 disrupts glycometabolic control
title How COVID-19 disrupts glycometabolic control
title_full How COVID-19 disrupts glycometabolic control
title_fullStr How COVID-19 disrupts glycometabolic control
title_full_unstemmed How COVID-19 disrupts glycometabolic control
title_short How COVID-19 disrupts glycometabolic control
title_sort how covid-19 disrupts glycometabolic control
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202046/
https://www.ncbi.nlm.nih.gov/pubmed/34127837
http://dx.doi.org/10.1038/s41574-021-00526-w
work_keys_str_mv AT starlingshimona howcovid19disruptsglycometaboliccontrol